Abstract
The association of matrix metalloproteinases (MMPs) with a variety of pathological states has stimulated impressive efforts over the past 20 years to develop synthetic compounds able to block potently and selectively the uncontrolled activity of these enzymes. Extremely potent inhibitors of MMPs have been developed, but in most cases these compounds act as broad-spectrum inhibitors of MMPs. Retrospective analysis suggests that the use of strong zinc-binding groups, like the hydroxamate function, to achieve potent MMP inhibition is responsible not only for the development of inhibitors displaying poor selectivity towards MMP members but also in their ability to potently block other unrelated zinc proteinases. The use of less avid zinc-binding group, like the phosphoryl group present in phosphinic peptide transition-state analogues, has led to a second generation of highly selective MMP inhibitors (MMP-12 selective inhibitors). The third generation of highly selective MMP inhibitors (MMP-13 selective inhibitors) possess no zinc-binding group and exploit the deep S1’ cavity present in some MMPs. Past research on the development of MMP inhibitors has probably underestimated the role of flexibility in the MMP active site and its impact in accommodating different inhibitor structures. Combined use of several biophysical techniques, like nuclear magnetic resonance, X-ray crystallography and isothermal titration experiments, should greatly improve our understanding of the specific structural and dynamic features that can be exploited to obtain series of inhibitors able to specifically block each MMP validated as a therapeutic target.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Yiotakis, A., Dive, V. (2008). Third-Generation MMP Inhibitors: Recent Advances in the Development of Highly Selective Inhibitors. In: Edwards, D., Høyer-Hansen, G., Blasi, F., Sloane, B.F. (eds) The Cancer Degradome. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69057-5_38
Download citation
DOI: https://doi.org/10.1007/978-0-387-69057-5_38
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-69056-8
Online ISBN: 978-0-387-69057-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)